Rho
|
4.07
|
NO
|
NO
|
NO
|
NO
|
NO
|
Sap25
|
3.13
|
NO
|
NO
|
NO
|
NO
|
NO
|
Srp54a
|
2. 50
|
− 1.16
|
3.25
|
SRP-dependent cotranslational protein targeting to membrane; response to drug
|
Nuclear speck
|
GTP binding, GTPase activity, drug binding, etc.
|
Mouse_newGene_24952
|
2.06
|
−1.17
|
2.87
|
NO
|
NO
|
NO
|
Gm38394
|
1.89
|
−1.35
|
NO
|
NO
|
NO
|
Transcription factor activity, sequence-specific DNA binding, RNA polymerase II regulatory region sequence-specific DNA binding, protein dimerization activity
|
Mouse_newGene_25840
|
1.76
|
−3.91
|
NO
|
NO
|
NO
|
NO
|
Mouse_newGene_3409
|
1.64
|
−3.60
|
NO
|
Humoral immune response mediated by circulating immunoglobulin, positive regulation of peptidyl-tyrosine phosphorylation, early endosome to late endosome transport, etc.
|
Immunoglobulin complex, circulating, external side of plasma membrane, B cell receptor complex
|
Antigen binding, transmembrane signaling receptor activity
|
Mouse_newGene_21033
|
1.51
|
−1.37
|
NO
|
NO
|
NO
|
NO
|
Mouse_newGene_34719
|
1.37
|
NO
|
NO
|
NO
|
NO
|
GTPase activator activity
|
Mouse_newGene_1240
|
1.28
|
−1.17
|
1.16
|
Negative regulation of peptidase activity
|
Extracellular region
|
Ligase activity, serine-type endopeptidase inhibitor activity
|
Mouse_newGene_4366
|
1.26
|
NO
|
1.63
|
NO
|
NO
|
NO
|
Tmem229a
|
1.26
|
NO
|
NO
|
NO
|
NO
|
NO
|
Mouse_newGene_3520
|
1.24
|
−0.91
|
0.98
|
Response to hormone, positive regulation of stress-activated MAPK cascade, negative regulation of microtubule depolymerization, etc.
|
Cytoplasmic microtubule
|
Ligase activity, ubiquitin protein ligase binding
|
Rapgef5
|
1.23
|
−1.28
|
0.92
|
Small gtpase-mediated signal transduction, positive regulation of gtpase activity
| |
GTP-dependent protein binding
|
Mapk14
|
1.22
|
NO
|
0.75
|
Lipopolysaccharide-mediated signaling pathway, response to muscle stretch, etc.
|
Spindle pole
|
Protein phosphatase binding, protein c-terminus binding
|
Slc5a1
|
1.17
|
NO
|
NO
|
NO
|
NO
|
NO
|
Kcna2
|
1.16
|
−2.43
|
NO
|
NO
|
NO
|
NO
|
Mouse_newGene_31701
|
1.14
|
NO
|
0.98
|
Response to oxidative stress, negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, etc.
|
Lamellipodium, CD95 death-inducing signaling complex, growth cone, etc.
|
Rac GTPase binding, GTPase activator activity, diacylglycerol choline phosphotransferase activity, etc.
|
Crispld2
|
1.13
|
NO
|
NO
|
Lung development, face morphogenesis, extracellular matrix organization
|
Proteinaceous extracellular matrix, transport vesicle
|
Heparin binding
|
Mouse_newGene_25226
|
1.13
|
−1.03
|
NO
|
NO
|
NO
|
NO
|
Plekhs1
|
1.11
|
−0.86
|
NO
|
NO
|
NO
|
NO
|
Pcdhgb7
|
1.11
|
NO
|
NO
|
Nervous system development, synapse organization, cell-cell signaling, etc.
|
NO
|
NO
|
Zfp273
|
1.10
|
−1.91
|
NO
|
NO
|
NO
|
NO
|
Gpr27
|
1.09
|
NO
|
1.33
|
Positive regulation of insulin secretion involved in cellular response to glucose stimulus
|
NO
|
NO
|
Mouse_newGene_25949
|
1.09
|
−1.81
|
1.05
|
Response to lead ion
|
Growth cone, filopodium
|
Cholesterol binding
|
Mouse_newGene_12272
|
1.09
|
−1.33
|
NO
|
NO
|
NO
|
NO
|
Jmjd8
|
1.09
|
−0.88
|
0.73
|
NO
|
NO
|
NO
|
Mouse_newGene_6388
|
1.08
|
−2.82
|
NO
|
NO
|
NO
|
NO
|
Arhgap19
|
1.07
|
−1.30
|
NO
|
Signal transduction
|
NO
|
GTPase activator activity
|
Zkscan7
|
1.06
|
−1.75
|
NO
|
NO
|
NO
|
NO
|